Cancer rates rising more quickly among younger people, international research finds

LONDON, 6 OCTOBER 2026 —

International research published on Monday reveals a sharp and statistically significant rise in early-onset cancers among younger populations in England, the United States, and the Netherlands, prompting urgent warnings from health experts that lifestyle factors are driving a public health crisis.

The findings carry profound implications for global health policy and individual lifestyle choices, as experts argue that modifiable risk factors are now costing thousands of lives annually.

While cancer remains predominantly a disease of older adults, with the median age at diagnosis still above 60, the trajectory among those under 50 is described by researchers as a "ticking timebomb." The data indicates that the rate of increase in early-onset cases is outpacing that of other age groups, a divergence that signals a fundamental change in the epidemiology of the disease.

This shift challenges traditional prevention strategies that have historically focused on older demographics and suggests that interventions must now target younger cohorts to mitigate future mortality rates.

In England, the data reveals a stark escalation in specific cancer types over the past two decades. The number of people under 50 diagnosed with prostate cancer has quadrupled since 2001, rising from one case per 100,000 people to 3.6 per 100,000 in 2023. Similarly, early-onset bowel cancer diagnoses more than doubled, with incidence rates leaping from 3.9 per 100,000 in 2001 to 8.4 per 100,000 in 2023.

Uterine and kidney cancers also saw their rates double among the under-50 demographic, reaching 3.9 and 3 per 100,000 respectively. These figures represent a substantial departure from historical baselines and indicate a rapid deterioration in health outcomes for younger men and women in the region.

The United States presents a parallel trend, with official data since 2000 showing that kidney cancer incidence among patients under 50 more than doubled, climbing from 2.5 per 100,000 in 2000 to 5.3 per 100,000 in 2023. Bowel, uterine, and pancreatic cancers all increased by more than 50% in the same age group, while breast cancer incidence rose by approximately 20%.

In the Netherlands, researchers identified significant increases in early-onset bowel, kidney, liver, and cervical cancers. The consistency of these trends across three distinct healthcare systems and geographical regions strengthens the evidence that the rise in early-onset cancer is a global phenomenon rather than an artifact of local diagnostic practices or data collection methods.

Experts attribute this surge primarily to the growing global obesity epidemic, poor dietary habits, and insufficient physical activity. Dr Giota Mitrou, the executive director of research and policy at the World Cancer Research Fund, described the trajectory as "concerning," emphasizing the human cost behind the statistics. "Behind every figure is a person facing cancer earlier than they, their family and often their doctor would expect," Mitrou said.

She noted that while cancer is still much more common in older adults, the changing patterns among younger generations must be treated as a serious research and cancer prevention priority. The WCRF highlighted that about 40% of cancers are linked to modifiable risks, including overweight and obesity, diet, alcohol consumption, smoking, and environmental exposures such as pollutants, chemicals, plastics, and water and air pollution.

Mark Lawler, professor of digital health and the chair in translational cancer genomics at Queen’s University Belfast, offered a stark assessment of the situation. He called the problem "a ticking timebomb that we need to [defuse] as quickly as possible, otherwise the numbers will undoubtedly continue to grow." Lawler added that the overall trend is particularly worrying because it emerges against a backdrop of lifestyle factors that are already contributing to thousands of deaths.

His comments underscore the urgency of addressing the root causes of the rise in early-onset cancer, suggesting that without immediate and effective intervention, the burden on healthcare systems and the loss of life will continue to escalate.

Despite the alarming trends, the data also shows a notable exception: lung cancer rates among the under-50s declined in all three countries studied. This decrease is attributed to continuing declines in smoking rates in these nations, providing a counter-example that demonstrates the potential impact of successful public health campaigns targeting specific risk factors.

However, this positive trend in lung cancer does not offset the sharp increases in other cancer types, which are linked to a broader range of lifestyle and environmental factors that remain prevalent in modern society. The contrast highlights the complexity of cancer prevention, where success in one area does not guarantee progress in others.

Dr Vanessa Gordon-Dseagu, research translation manager at WCRF, provided further insight into the drivers of the trend. "While we don’t completely understand why more cancers are occurring in people under 50 years of age, it is likely that risk factors related to cancer – for example, overweight and obesity, diet, alcohol, consumption and smoking – play a role," she said.

Gordon-Dseagu also noted that increased public awareness of cancer symptoms means that people are more likely to seek healthcare when they experience them, leading to earlier diagnoses. However, she cautioned that "increased diagnosis does not explain the whole story and more research is needed to understand early-onset cancers." This distinction is crucial for policymakers, as it implies that while better detection is helpful, it does not address the underlying increase in disease incidence.

In response to the findings, King’s College London has announced a new trial involving 250,000 people, funded by Cancer Research UK, to investigate the increase in bowel cancer cases among younger adults. The study aims to achieve a clearer understanding of the balance between worsening risk factors and better detection in the observed rise.

This large-scale research initiative represents a significant investment in understanding the mechanisms behind early-onset cancer and could provide the evidence base needed for targeted interventions. The trial’s focus on bowel cancer reflects the severity of the increase in this specific type among younger populations in England.

The UK government has also responded to the findings, with a Department of Health and Social Care spokesperson stating that the results "underline why early diagnosis is at the heart of our national cancer plan." The spokesperson outlined several initiatives, including investing in new technologies to speed up diagnosis, expanding genetic testing, and supporting research to better understand the causes of cancer and who may be most at risk.

The department emphasized its commitment to prioritizing research into less-survivable and rarer cancers, with an ambition for three-quarters of people diagnosed by 2035 to be cancer-free or living well with cancer, a goal that would save 320,000 lives.

The government further noted that its newly announced national cancer board includes a specific representative for children and young people, acknowledging the devastating impact of getting cancer at an earlier stage of life. This structural change in health governance reflects a recognition that the needs of younger cancer patients are distinct and require dedicated attention.

The combination of new research trials, technological investments, and policy adjustments signals a comprehensive approach to addressing the rising tide of early-onset cancer. As the data from England, the US, and the Netherlands continues to paint a picture of a changing cancer landscape, the focus is shifting toward understanding and mitigating the lifestyle and environmental factors that are driving this trend, with the aim of reversing the upward trajectory in the coming decades.

Related: Dr Giota Mitrou